hafnium has been researched along with Colorectal Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Marill, J; Mohamed Anesary, N; Paris, S | 1 |
| Darmon, A; Marill, J; Mohamed Anesary, N; Paris, S; Zhang, P | 1 |
| DuRoss, AN; Landry, MR; Neufeld, MJ; Sun, C; Thomas, CR | 1 |
3 other study(ies) available for hafnium and Colorectal Cancer
| Article | Year |
|---|---|
DNA damage enhancement by radiotherapy-activated hafnium oxide nanoparticles improves cGAS-STING pathway activation in human colorectal cancer cells.
Topics: Colorectal Neoplasms; DNA Damage; Hafnium; HCT116 Cells; Humans; Membrane Proteins; Nanoparticles; Nucleotidyltransferases; Oxides; Signal Transduction | 2019 |
Radiotherapy-Activated Hafnium Oxide Nanoparticles Produce Abscopal Effect in a Mouse Colorectal Cancer Model.
Topics: Animals; Antineoplastic Agents, Immunological; Biological Availability; CD8-Positive T-Lymphocytes; Colorectal Neoplasms; Female; Hafnium; Metal Nanoparticles; Mice, Inbred BALB C; Neoplasms, Experimental; Oxides | 2020 |
Fucoidan-coated nanoparticles target radiation-induced P-selectin to enhance chemoradiotherapy in murine colorectal cancer.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chemoradiotherapy; Colorectal Neoplasms; Disease Models, Animal; Drug Delivery Systems; Gene Expression Regulation, Neoplastic; Hafnium; Humans; Mice; Nanoparticles; P-Selectin; Phthalazines; Poly(ADP-ribose) Polymerase Inhibitors; Polysaccharides; Radiation Tolerance; Temozolomide | 2021 |